Report post
The impact of AI on drug development is a hot topic. Novartis' CEO shares insights on how AI will transform this field. AI drug discovery stocks are gaining attention, with companies leveraging AI to accelerate drug development. Pharmaceutical firms are utilizing AI for various purposes, such as identifying new targets and optimizing compounds. Lantern Pharma is one such firm, employing AI to revolutionize drug development processes.

The World's Leading Crypto Trading Platform

Get my welcome gifts